CRIT peptide interacts with factor B and interferes with alternative pathway activation

Kwok-Min Hui1, Bergljót Magnadóttir, Jürg A Schifferli

  • 1University Hospital Basel, Immunonephrology, Department of Research, Hebelstrasse 20, CH-4031 Basel, Switzerland. 12min@mail.hongkong.com

Insights

Complement C2 receptor inhibitor trispanning (CRIT) peptide CRIT-H17 blocks alternative pathway (AP) complement activation by inhibiting factor B cleavage. This peptide shows potential for modulating AP-driven inflammatory diseases.

Area of Science:

  • Immunology
  • Complement system biology

Background:

  • Complement C2 receptor inhibitor trispanning (CRIT) targets the classical pathway (CP) C3 convertase.
  • The C-terminal peptide CRIT-H17 mimics C4b binding to C2.
  • Similarities exist between CP and alternative pathway (AP) C3 convertases.

Purpose of the Study:

  • To investigate the effect of CRIT-H17 on the AP of the complement system.
  • To determine the mechanism of CRIT-H17 inhibition on AP activation.

Main Methods:

  • ELISA and immunoblot assays to detect CRIT-H17 binding to factor B (FB).
  • Inhibition assays for factor D-mediated cleavage of FB.
  • Hemolytic assays using C2-deficient serum to assess AP activation.

Main Results:

  • CRIT-H17 blocked factor D-mediated cleavage of factor B.
  • CRIT-H17 directly bound to factor B.
  • CRIT-H17 did not affect C3bB complex assembly or exhibit decay-accelerating activity.
  • CRIT-H17 inhibited AP complement activation in a hemolytic assay.

Conclusions:

  • CRIT-H17 peptide inhibits AP complement activation by interfering with factor B function.
  • CRIT-H17 represents a potential therapeutic agent for AP-mediated diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...